APA (7th ed.) Citation

Yim, S. Y., Lee, S. H., Baek, S., Sohn, B., Jeong, Y. S., Kang, S., . . . Lee, J. (2024, October). Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial. Clinical and Molecular Hepatology.

Chicago Style (17th ed.) Citation

Yim, Sun Young, et al. "Genomic Biomarkers to Predict Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma: Insights from the IMbrave150 Trial." Clinical and Molecular Hepatology Oct. 2024.

MLA (9th ed.) Citation

Yim, Sun Young, et al. "Genomic Biomarkers to Predict Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma: Insights from the IMbrave150 Trial." Clinical and Molecular Hepatology, Oct. 2024.